Skip to content
PubMed This is a summary of 44 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 44 referenced papers

Top Institutions

Ranked by publications Top 5 institutions
01
02

Chinese Academy of Medical Sciences & Peking Union Medical College

Beijing, China

2 papers
03

Fukushima Medical University

Fukushima, Japan

2 papers
04

Jilin University

Changchun, China

2 papers
05

Temple University

Philadelphia, United States

2 papers
Contributors INSERMSaira Agarwala

References

References (44)
  1. 1

    Assessment and effective targeting of Interleukin-1 in multicentric reticulohistyocytosis.

    Aouba A, Leclerc-Mercier S, Fraitag S, et al.

    Joint bone spine 2015; (82(4)):280-3.

    PMID: 25776445
  2. 2

    Multicentric reticulohistiocytosis: a critical review.

    Selmi C, Greenspan A, Huntley A, Gershwin ME

    Current rheumatology reports 2015; (17(6)):511 doi:10.1007/s11926-015-0511-6.

    PMID: 25900189
  3. 3

    Erythema, papules, and arthralgia associated with liver cancer: report of a rare case of multicentric reticulohistiocytosis.

    Hu L, Mei JH, Xia J, et al.

    International journal of clinical and experimental pathology 2015; (8(3)):3304-7.

    PMID: 26045857
  4. 4

    Bilateral Total Hip Arthroplasty in a Rare Case of Multicentric Reticulohistiocytosis.

    Saibaba B, Sen RK, Das A, Sharma A

    Clinics in orthopedic surgery 2015; (7(4)):509-14 doi:10.4055/cios.2015.7.4.509.

    PMID: 26640636
  5. 5

    Organizing pneumonia associated with multicentric reticulohistiocytosis.

    Yoshimura K, Sato J, Imokawa S, et al.

    Respirology case reports 2015; (3(4)):125-7 doi:10.1002/rcr2.125.

    PMID: 26740877
  6. 6

    Tumor necrosis factor antagonists in the treatment of multicentric reticulohistiocytosis: Current clinical evidence.

    Zhao H, Wu C, Wu M, et al.

    Molecular medicine reports 2016; (14(1)):209-17 doi:10.3892/mmr.2016.5253.

    PMID: 27175854
  7. 7

    Efficacy of Vinblastine and Prednisone in Multicentric Reticulohistiocytosis With Onset in Infancy.

    Jha VK, Kumar R, Kunwar A, et al.

    Pediatrics 2016; (137(6)).

    PMID: 27199388
  8. 8

    Looks Can Be Deceiving: A Case Report on Multicentric Reticulohistiocytosis Successfully Treated with Rituximab.

    Lim K, D'Souza J, Vasquez JB, Vuyyuru S

    Cureus 2017; (9(5)):e1220 doi:10.7759/cureus.1220.

    PMID: 28589069
  9. 9

    Multicentric Reticulohistiocytosis with Dermatomyositis-like Eruptions.

    Shima N, Murosaki T, Nagashima T, et al.

    Internal medicine (Tokyo, Japan) 2017; (56(15)):2063-2066 doi:10.2169/internalmedicine.56.8297.

    PMID: 28768982
  10. 10

    [Multicentric reticulohistiocytosis is a rare form of paraneoplasia].

    Anderson AM, Todberg T, Kofoed K, et al.

    Ugeskrift for laeger 2018; (180(1)).

    PMID: 29298742
  11. 11

    The utility of FDG-PET/CT imaging in the evaluation of multicentric reticulohistiocytosis: A case report.

    Asano T, Suzutani K, Watanabe A, et al.

    Medicine 2018; (97(33)):e11449 doi:10.1097/MD.0000000000011449.

    PMID: 30113451
  12. 12

    Multicentric reticulohistiocytosis: a case report.

    Farokhi A, van Vugt RM, Hoekzema R, Nurmohamed MT

    BMC research notes 2018; (11(1)):647 doi:10.1186/s13104-018-3753-3.

    PMID: 30180908
  13. 13

    Clinical factors associated with cutaneous histopathologic findings in dermatomyositis.

    Wolstencroft PW, Rieger KE, Leatham HW, Fiorentino DF

    Journal of cutaneous pathology 2019; (46(6)):401-410 doi:10.1111/cup.13442.

    PMID: 30737826
  14. 14

    Multicentric Reticulohistiocytosis: Elective Excision of Symptomatic Hand Nodules With 1-Year Follow-Up.

    Mead M, Baes T, Dass G

    The Journal of hand surgery 2020; (45(5)):457.e1-457.e5 doi:10.1016/j.jhsa.2019.06.001.

    PMID: 31320232
  15. 15

    Multicentric reticulohistiocytosis: the Mayo Clinic experience (1980-2017).

    Sanchez-Alvarez C, Sandhu AS, Crowson CS, et al.

    Rheumatology (Oxford, England) 2020; (59(8)):1898-1905 doi:10.1093/rheumatology/kez555.

    PMID: 31742640
  16. 16

    Thalidomide, A Rational Agent for Treatment of Multicentric Reticulohistiocytosis.

    Zinn DJ, Eckstein O, Olsen ML, et al.

    Dermatology case reports 2019; (4(1)) doi:10.35248/2684-124X.19.4.152.

    PMID: 32529194
  17. 17

    Multicentric reticulohistiocytosis: A case report with response to adalimumab.

    Kim S, Khatchaturian EM, Dehesa L

    Clinical case reports 2020; (8(8)):1560-1563 doi:10.1002/ccr3.2926.

    PMID: 32884795
  18. 18

    Multicentric Reticulohistiocytosis Exhibiting Positive HLA-B*07 and HLA-B*08: A Case Report.

    Rezuș E, Burlui MA, Cardoneanu A, et al.

    Medicina (Kaunas, Lithuania) 2020; (56(9)) doi:10.3390/medicina56090456.

    PMID: 32911791
  19. 19

    Paraneoplastic Multicentric Reticulohistiocytosis on 18F-FDG PET/CT Breast Carcinoma Follow-up.

    Dietz M, Debarbieux S, Righetti M, et al.

    Clinical nuclear medicine 2021; (46(5)):e253-e255 doi:10.1097/RLU.0000000000003417.

    PMID: 33323726
  20. 20

    Skin Manifestation Associated With Multicentric Reticulohistiocytosis.

    Yamamoto T

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2022; (28(1)):e234-e239 doi:10.1097/RHU.0000000000001679.

    PMID: 33337805
  21. 21

    Multicentric reticulohistiocytosis masquerading as cutaneous connective tissue disease.

    Fronek L, Bindernagel R, Segars K, Miller R

    Dermatology online journal 2021; (27(3)).

    PMID: 33865276
  22. 22

    [Multicentric reticulohistiocytosis: A case report].

    Zhai L, Qiu N, Song H

    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2021; (53(6)):1183-1187.

    PMID: 34916702
  23. 23

    Letter to Editor: Characterizing the Lack of Specificity of the Histopathological Findings Seen in Multicentric Reticulohistiocytosis and Reticulohistiocytoma.

    Agarwala S, Hafeez F

    Annals of clinical and laboratory science 2021; (51(6)):894-895.

    PMID: 34921045
  24. 24

    Case Report: Multicentric Reticulohistiocytosis Associated With Posterior Mediastinal Adenosquamous Carcinoma, Antinuclear Antibody Positivity and Lupus Anticoagulant Positivity.

    Tang Z, Wang X, Xia Z, et al.

    Frontiers in immunology 2021; (12()):749669 doi:10.3389/fimmu.2021.749669.

    PMID: 35069525
  25. 25

    Clinical characteristics of multicentric reticulohistiocytosis and distinguished features from rheumatoid arthritis: a single-center experience in China.

    Zou XJ, Qiao L, Li F, et al.

    Orphanet journal of rare diseases 2022; (17(1)):164 doi:10.1186/s13023-022-02311-y.

    PMID: 35413870
  26. 26

    Multicentric reticulohistiocytosis with prominent skin lesions and arthritis: A case report.

    Xu XL, Liang XH, Liu J, et al.

    World journal of clinical cases 2022; (10(22)):7913-7923 doi:10.12998/wjcc.v10.i22.7913.

    PMID: 36158473
  27. 27

    Multicentric Reticulohistiocytosis Associated with an Early Form of Systemic Lupus Erythematosus: A Case Report of a Rare Disease, with Mini Review of the Literature.

    Mariotti EB, Corrà A, Lemmi E, et al.

    Journal of clinical medicine 2022; (11(21)) doi:10.3390/jcm11216529.

    PMID: 36362761
  28. 28

    A Novel Case of Multicentric Reticulohistiocytosis Associated with Renal Cell Carcinoma Successfully Treated with Infliximab and Methotrexate.

    Patel S, Alhajj M, Brimhall C

    Case reports in dermatology 2023; (15(1)):10-16 doi:10.1159/000528254.

    PMID: 36632441
  29. 29

    Systemic lupus erythematosus with multicentric reticulohistiocytosis: A case report.

    Liu PP, Shuai ZW, Lian L, Wang K

    World journal of clinical cases 2023; (11(2)):456-463 doi:10.12998/wjcc.v11.i2.456.

    PMID: 36686350
  30. 30

    Successful Treatment of a Patient with Rheumatoid Arthritis and Comorbid Multicentric Reticulohistiocytosis.

    Chang F, Wu C, Wang T, Wang Q

    Rheumatology and immunology research 2022; (3(3)):143-146 doi:10.2478/rir-2022-0023.

    PMID: 36788972
  31. 31

    Multicentric reticulohistiocytosis with eosinophilic gastroenteritis: An unusual relationship.

    Fan J, Jiang T, Qin Y, et al.

    International journal of rheumatic diseases 2023; (26(7)):1377-1380 doi:10.1111/1756-185X.14625.

    PMID: 36823772
  32. 32

    Reddish-brown, papulonodular skin lesions in the periungual region.

    Nosewicz J, Moad JC, Kaffenberger J

    Dermatology online journal 2023; (29(1)) doi:10.5070/D329160219.

    PMID: 37040916
  33. 33

    Multicentric Reticulohistiocytosis Presenting As Acute Pericarditis With Moderate-Sized Pericardial Effusion: A Case Report and Review of Multicentric Reticulohistiocytosis Treatment.

    Mandyam S, Onteddu J, Ray R, et al.

    Cureus 2023; (15(6)):e39953 doi:10.7759/cureus.39953.

    PMID: 37416020
  34. 34

    Multicentric Reticulohistiocytosis-A rare and disabling disease.

    Ashaolu O, Ng S, Smale S, Hughes J

    Clinical case reports 2023; (11(9)):e7846 doi:10.1002/ccr3.7846.

    PMID: 37645054
  35. 35

    A case report of multicentric reticulohistiocytosis with atypical cutaneous presentation.

    Chen X, An L, Jiang Z, Jia Y

    Frontiers in immunology 2024; (15()):1344313 doi:10.3389/fimmu.2024.1344313.

    PMID: 38426104
  36. 36

    Multicentric reticulohistiocytosis revealing a ductal breast cancer in situ: A case report with dermoscopic and histopathological findings.

    Palma Peña S, Neely Erdos G, Buchroithner Haase C, Pinto Viguera C

    Medwave 2024; (24(5)):e2914 doi:10.5867/medwave.2024.05.2914.

    PMID: 38896878
  37. 37

    Multicentric reticulohistiocytosis with oral and laryngeal involvement in association with autoimmune/inflammatory syndrome induced by adjuvants: Expanding the spectrum of two uncommon entities.

    Girolami I, Kluge RW, Gallmetzer L, et al.

    Modern rheumatology case reports 2025; (9(1)):200-206 doi:10.1093/mrcr/rxae040.

    PMID: 39096518
  38. 38

    Multicentric Reticulohistiocytosis.

    Goldberg LA, Hsu S

    Skinmed 2024; (22(6)):452-453.

    PMID: 39748578
  39. 39

    Multicentric Reticulohistiocytosis-Histopathologic Spectrum in Indian Patients.

    Murugesu L, Tirumalae R

    The American Journal of dermatopathology 2025; (47(6)):428-432 doi:10.1097/DAD.0000000000002944.

    PMID: 40105306
  40. 40

    Malignancy-associated Multicentric Reticulohistocytosis Mimicking Dermatomyositis-like Features, with a Significant Ultrasound Finding.

    Inomata H, Asatani S, Ikumi N, et al.

    Internal medicine (Tokyo, Japan) 2026; (65(12)):1710-1715 doi:10.2169/internalmedicine.6032-25.

    PMID: 41192909
  41. 41

    A refractory polyarthritis revealing a multicentric reticulohistiocytosis.

    Deville-Cavellin O, Nallet A, Ralandison S, et al.

    Modern rheumatology case reports 2026; (10(1)) doi:10.1093/mrcr/rxag021.

    PMID: 41786636
  42. 42

    Upadacitinib-Induced Remission in Multicentric Reticulohistiocytosis: Expanding the Therapeutic Role of JAK Inhibition.

    Pamfil C, Taki MA, Candrea E, et al.

    International journal of molecular sciences 2026; (27(6)) doi:10.3390/ijms27062898.

    PMID: 41898754
  43. 43

    Successful treatment of multicentric reticulohistiocytosis with JAK inhibitor: a case series.

    Hilliquin S, Dupin N, Franck N, et al.

    RMD open 2026; (12(2)) doi:10.1136/rmdopen-2025-006661.

    PMID: 42097694
  44. 44

    Multicentric Reticulohistiocytosis Progressing to Erythroderma After Long-Term Disease Progression.

    Maruyama A, Masuda K, Fukumoto T

    The Journal of dermatology 2026; doi:10.1111/1346-8138.70415.

    PMID: 42478336